Azithromycin 1.5% Ophthalmic Solution: In Purulent Bacterial or Trachomatous Conjunctivitis

ISSN： 0012-6667

Source： Drugs, Vol.72, Iss.3, 2012-02, pp. : 361-373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Moxifloxacin 0.5% Ophthalmic Solution: In Bacterial Conjunctivitis

By Keating Gillian M.

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 89-99

Adis International

Access to resources Recommend Favorite

Besifloxacin Ophthalmic Suspension 0.6% Administered Twice Daily for 3 Days in the Treatment of Bacterial Conjunctivitis in Adults and Children

By DeLeon Jesse

Clinical Drug Investigation, Vol. 32, Iss. 5, 2012-05 ,pp. : 303-317

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Conjunctivitis: Data from Six Clinical and Phase I Safety Studies

By Comstock Timothy L.

Clinical Drug Investigation, Vol. 30, Iss. 10, 2010-10 ,pp. : 675-685

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Besifloxacin Ophthalmic Suspension 0.6% in Children and Adolescents with Bacterial Conjunctivitis: A Post Hoc, Subgroup Analysis of Three Randomized, Double-Masked, Parallel-Group, Multicenter Clinical Trials

By Comstock Timothy L.

Pediatric Drugs, Vol. 12, Iss. 2, 2010-04 ,pp. : 105-112

Adis International

Access to resources Recommend Favorite

Ketorolac 0.45% Ophthalmic Solution

By McCormack Paul L.

Drugs & Aging, Vol. 28, Iss. 7, 2011-07 ,pp. : 583-589

Adis International

Access to resources Recommend Favorite